Pre-learning activity

How would you rate your familiarity with genetic testing for patients with ovarian and/or breast cancer?

How confident are you in identifying patients with ovarian and/or breast cancer who may benefit from genetic testing?

Are you aware that Medicare funding is available for physicians to order genetic testing of the BRCA1 and BRCA2 genes in eligible patients with high-grade, non-mucinous ovarian cancer?

Are you aware that Medicare funding is available for physicians to order genetic testing of the BRCA1 and BRCA2 genes in eligible patients with breast cancer?

How often do you currently refer high-risk patients to a family cancer centre or genetics service for BRCA1 and BRCA2 genetic testing?

How would you rate your familiarity with mainstream genetic testing for genetic mutations in patients with ovarian and/or breast cancer?

Are you familiar with how and who to contact at your local family cancer centre or genetics service?

Please indicate your level of agreement with the following statement: ‘I have the necessary time to discuss genetic testing with patients who have ovarian and/or breast cancer.’

Please indicate your level of agreement with the following statement: ‘I have the necessary knowledge to discuss genetic testing with patients who have ovarian and/or breast cancer.’

Please indicate your level of agreement with the following statement: ‘I feel ready to address/respond to patients’ questions and reactions to the offer of genetic testing and/or a genetic test result.’

Please indicate your level of agreement with the following statement: ‘I understand under what circumstances I can/should contact the family cancer centre or genetics service during mainstream genetic testing for my patient with ovarian/breast cancer.’

Please indicate if you have previously completed training about mainstream genetic testing from any of the following sources. (Select all that apply)